New ProActiveTM study from Natera will test for rejection in 3,000 kidney transplants
Natera announced a nationwide registry study for kidney transplant recipients called ProActive. This is one of the largest known prospective studies to date, incorporating donor-derived cell-free DNA testing into medical management of organ transplant recipients. June 24, 2019